Metabolic Syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Meet the Global consensus on Metabolic Syndrome of the International Diabetes Alliance, abdominal obesity (waist circumference >=90cm for men and >=80cm for women); 1. HDL-c (high-density lipoprotein cholesterol) 1.7mmol/L; 3. SBP (systolic blood pressure) >=130mmHg, or DBP (diastolic blood pressure) >=85mmHg; 4. FPG (fasting blood glucose) 5.6 to 11.1 mmol/L; 5. 9.0% or greater HbA1C; Participants are informed of this study and volunteered to participate in the study.
Exclusion criteria
Exclusion criteria: 1. type 1 DM or special type DM, or GDM; Serious complications of liver, kidney, brain, heart and other important organs and systems; 2. participants with other drug trials within the past 3 months; Antibiotics and microecological preparations were taken within 4 weeks; 3. poor blood glucose control and insulin injection >=30u; 4. secondary hypertension; 5. age =70 years; 6. associated with protein-wasting diseases; 7. diarrhea or other gastrointestinal diseases within the last 4 weeks; Previous history of gastrointestinal surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proteomics;the oxdiative stress factors;inflammation factors;body weight; | — |
Countries
China